Literature DB >> 19877800

Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Toni Frederick1, Pamela Burian, Norah Terrault, Mardge Cohen, Michael Augenbraun, Mary Young, Eric Seaberg, Jessica Justman, Alexandra M Levine, Wendy J Mack, Andrea Kovacs.   

Abstract

Although the primary mode of hepatitis C virus (HCV) transmission is exposure to blood products or injection drug use (IDU), studies have found varying independent risk factors for HCV infection among persons with no history of IDU or exposure to blood products. For HIV-infected women, sexual transmission may be another potential source of HCV infection. HIV-infected and HIV-negative women at risk for HIV enrolled in the Women's Interagency HIV Study (WIHS) during October 1994 to November 1995 and again between October 2001 and November 2002 were studied. Clinical and demographic factors associated with HCV seroprevalence were assessed in multivariate logistic regression models controlling for history of blood transfusion and IDU. Among 3636 women with HCV results, 31.5% were HCV antibody positive (HCV+) including 13.5% with no reported history of IDU or blood transfusions. Multivariate logistic regression analyses stratified on IDU showed that among women with no history of IDU, sex with an IDU male was independently associated with HCV positivity (odds ratio [OR] = 2.8, 95% confidence [CI] = 2.1, 3.8, p < 0.0001) after controlling for blood transfusion, age, HIV infection, unemployment, birth in the United States, history of hepatitis B infection, and current smoking status. Further stratification on HIV status showed that the association was significant only for the HIV+ (OR = 1.9, 95% CI = 1.3, 2.7, p = 0.0007) compared to the HIV- women (OR = 1.1, 95% CI = 0.4, 2.7) although these odds ratios were not significantly different (p = 0.25). For HIV-positive women with no reported history of IDU, sex with an IDU male was independently associated with HCV suggesting that sexual transmission may be an important mode of HCV transmission for these high-risk women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877800      PMCID: PMC2823487          DOI: 10.1089/apc.2009.0111

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  44 in total

1.  Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse.

Authors:  P Halfon; H Riflet; C Renou; Y Quentin; P Cacoub
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 2.  Hepatitis C virus infection in the United States.

Authors:  M J Alter
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

3.  Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection as a potential cofactor for HCV infection.

Authors:  Kimberly A Page-Shafer; Barbara Cahoon-Young; Jeffrey D Klausner; Scott Morrow; Fred Molitor; Juan Ruiz; Willi McFarland
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

4.  Heterosexual transmission of hepatitis C, hepatitis B, and HIV-1 in a sample of inner city women.

Authors:  J G Feldman; H Minkoff; S Landesman; J Dehovitz
Journal:  Sex Transm Dis       Date:  2000-07       Impact factor: 2.830

5.  Hepatitis B and C viruses and sexually transmitted disease patients in Jamaica.

Authors:  M Smikle; G Dowe; T Hylton-Kong; E Williams
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

6.  Accuracy of self-reports of acquired immunodeficiency syndrome and acquired immunodeficiency syndrome-related conditions in women.

Authors:  N A Hessol; S Schwarcz; N Ameli; G Oliver; R M Greenblatt
Journal:  Am J Epidemiol       Date:  2001-06-01       Impact factor: 4.897

Review 7.  HCV: epidemiology, modes of transmission and prevention of spread.

Authors:  P Pradat; C Trépo
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  2000-04

8.  Detection of hepatitis C virus in the semen of infected men.

Authors:  M Leruez-Ville; J M Kunstmann; M De Almeida; C Rouzioux; M L Chaix
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

9.  Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.

Authors:  A Neaigus; M Miller; S R Friedman; D C Des Jarlais
Journal:  J Infect Dis       Date:  2001-06-26       Impact factor: 5.226

10.  Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men.

Authors:  Thijis van de Laar; Oliver Pybus; Sylvia Bruisten; David Brown; Mark Nelson; Sanjay Bhagani; Martin Vogel; Alex Baumgarten; Marie-Laure Chaix; Martin Fisher; Hannelore Gotz; Gail V Matthews; Stefan Neifer; Peter White; William Rawlinson; Stanislav Pol; Jurgen Rockstroh; Roel Coutinho; Greg J Dore; Geoffrey M Dusheiko; M Danta
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

View more
  27 in total

1.  Hepatitis C virus infection and biological false-positive syphilis tests.

Authors:  M Augenbraun; A French; M Glesby; L Sanchez-Keeland; M Young; R Greenblatt; A Sharma
Journal:  Sex Transm Infect       Date:  2010-04       Impact factor: 3.519

Review 2.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Authors:  Susanna Naggie; Mark S Sulkowski
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 4.  Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

Authors:  Frederick L Altice; Adeeba Kamarulzaman; Vincent V Soriano; Mauro Schechter; Gerald H Friedland
Journal:  Lancet       Date:  2010-07-31       Impact factor: 79.321

Review 5.  Evolving epidemiology of hepatitis C virus in the United States.

Authors:  R Monina Klevens; Dale J Hu; Ruth Jiles; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

Review 6.  HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms.

Authors:  Lynn E Taylor; Tracy Swan; Kenneth H Mayer
Journal:  Clin Infect Dis       Date:  2012-07       Impact factor: 9.079

7.  Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.

Authors:  Vincent Lo Re; Bret Zeldow; Michael J Kallan; Janet P Tate; Dena M Carbonari; Sean Hennessy; Jay R Kostman; Joseph K Lim; Matthew Bidwell Goetz; Robert Gross; Amy C Justice; Jason A Roy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-07-19       Impact factor: 2.890

8.  Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984-2011.

Authors:  Mallory D Witt; Eric C Seaberg; Annie Darilay; Stephen Young; Sheila Badri; Charles R Rinaldo; Lisa P Jacobson; Roger Detels; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

9.  The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic.

Authors:  Lynn E Taylor; Julie A Foont; Allison K DeLong; Alysse Wurcel; Benjamin P Linas; Stacey Chapman; Michaela A Maynard; Susan Cu-Uvin; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2014-01       Impact factor: 5.078

Review 10.  Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.

Authors:  David L Wyles; Mark S Sulkowski; Douglas Dieterich
Journal:  Clin Infect Dis       Date:  2016-07-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.